Literature DB >> 1859442

Allosteric antagonists of the muscarinic acetylcholine receptor.

N H Lee1, E E el-Fakahany.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1859442     DOI： 10.1016/0006-2952(91)90703-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

1.  Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.

Authors:  Karen A Selz; Arnold J Mandell; Michael F Shlesinger; Vani Arcuragi; Michael J Owens
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

2.  Brain soluble fractions which modulate Na+, K+-ATPase activity likewise modify muscarinic receptor.

Authors:  G Rodríguez de Lores Arnaiz; P Schneider; C Peña
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

3.  Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.

Authors:  M Lysíková; K Fuksová; T Elbert; J Jakubík; S Tucek
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide.

Authors:  E A Thomas; M J Carson; M J Neal; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Activation of muscarinic acetylcholine receptors via their allosteric binding sites.

Authors:  J Jakubík; L Bacáková; V Lisá; E E el-Fakahany; S Tucek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

6.  The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells.

Authors:  Lauren T May; Tim J Self; Stephen J Briddon; Stephen J Hill
Journal:  Mol Pharmacol       Date:  2010-06-22       Impact factor: 4.436

7.  Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease.

Authors:  Ciria C Hernandez; Jose H Nascimento; Elen A Chaves; Patricia C Costa; Masako O Masuda; Eleonora Kurtenbach; Antonio C Campos DE Carvalho; Luis E Gimenez
Journal:  J Recept Signal Transduct Res       Date:  2008       Impact factor: 2.092

8.  Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Neurochem Res       Date:  2008-12-12       Impact factor: 3.996

9.  Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor.

Authors:  D B Jacoby; G J Gleich; A D Fryer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Characterization of the interaction of the cervane alkaloid, imperialine, at muscarinic receptors in vitro.

Authors:  R M Eglen; G C Harris; H Cox; A O Sullivan; E Stefanich; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.